Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omri Zveik

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Neurology|May 29, 2024
Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settingsAriel Rechtman, Tal Freidman-Korn, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|September 11, 2025
A predictive model for triple negative optic neuritis patients: Identifying the subset of patients with favorable outcomesAriel Rechtman, Tal Friedman-Korn, Sol Zamir, et al.
International Journal of Molecular Sciences|July 9, 2022
Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in AstrocytesOmri Zveik, Ariel Rechtman, Nitzan Haham, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosisLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
Frontiers in Immunology|August 8, 2025
Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathwayAriel Rechtman, Omri Zveik, Lyne Shweiki, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 26, 2023
Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple SclerosisShahar Kahila, Omri Zveik, Netta Levin, et al.
Glia|March 10, 2022
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cellsOmri Zveik, Nina Fainstein, Ariel Rechtman, et al.
Annals of Clinical and Translational Neurology|November 6, 2024
Subclinical imaging activity in multiple sclerosis patients during war-related psychological stressOmri Zveik, Tal Friedman-Korn, Ariel Rechtman, et al.
Frontiers in Neurology|April 11, 2022
Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease CourseAriel Rechtman, Livnat Brill, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccineLivnat Brill, Ariel Rechtman, Alla Shifrin, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Neurology|May 29, 2024
Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settingsAriel Rechtman, Tal Freidman-Korn, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|September 11, 2025
A predictive model for triple negative optic neuritis patients: Identifying the subset of patients with favorable outcomesAriel Rechtman, Tal Friedman-Korn, Sol Zamir, et al.
International Journal of Molecular Sciences|July 9, 2022
Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in AstrocytesOmri Zveik, Ariel Rechtman, Nitzan Haham, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosisLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
Frontiers in Immunology|August 8, 2025
Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathwayAriel Rechtman, Omri Zveik, Lyne Shweiki, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 26, 2023
Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple SclerosisShahar Kahila, Omri Zveik, Netta Levin, et al.
Glia|March 10, 2022
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cellsOmri Zveik, Nina Fainstein, Ariel Rechtman, et al.
Annals of Clinical and Translational Neurology|November 6, 2024
Subclinical imaging activity in multiple sclerosis patients during war-related psychological stressOmri Zveik, Tal Friedman-Korn, Ariel Rechtman, et al.
Frontiers in Neurology|April 11, 2022
Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease CourseAriel Rechtman, Livnat Brill, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccineLivnat Brill, Ariel Rechtman, Alla Shifrin, et al.
Pageof 3